Cargando…
PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells
Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with very poor prognosis. Therefore, it is important to fully understand the molecular mechanism underlying its occurrence and development. Pumilio RNA-binding family member 1 (PUM1) has been reported to function as an oncogene in ovarian...
Autores principales: | Dai, Haisu, Shen, Kaicheng, Yang, Yishi, Su, Xingxing, Luo, Yuandeng, Jiang, Yan, Shuai, Ling, Zheng, Ping, Chen, Zhiyu, Bie, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687830/ https://www.ncbi.nlm.nih.gov/pubmed/31395860 http://dx.doi.org/10.1038/s41419-019-1839-z |
Ejemplares similares
-
PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer
por: Yang, Yishi, et al.
Publicado: (2021) -
Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway
por: Su, Xingxing, et al.
Publicado: (2020) -
Emerging Role for the PERK/eIF2α/ATF4 in Human Cutaneous Leishmaniasis
por: Dias-Teixeira, Karina Luiza, et al.
Publicado: (2017) -
ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis
por: Wang, Anbin, et al.
Publicado: (2019) -
Knockdown of NUPR1 inhibits angiogenesis in lung cancer through IRE1/XBP1 and PERK/eIF2α/ATF4 signaling pathways
por: Wang, Lihuai, et al.
Publicado: (2023)